Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis--Behçet's syndrome. 2001

S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
Division of Hematology, Kyoto Second Red Cross Hospital, 355-5 Haruobi Kamigyo-ku, First Department of Internal Medicine, Kyoto Prefectural University of Medicine, 465 Kajii Kamigyo-ku, Kyoto, Japan. shkimu@aol.com

Only 12 myelodysplastic syndrome (MDS) cases with Behçet's syndrome have been previously reported and trisomy 8 was found to have accumulated in all these patients. Five of the cases had complications in the form of multiple intestinal ulcers, which is one of the symptoms of Behçet's syndrome. To investigate the relationship between trisomy 8 and multiple intestinal ulcers in MDS patients, we analyzed 46 MDS cases treated in our hospital over the last decade, and trisomy 8 was observed in eight of them. Three of these cases had complications of both multiple intestinal ulcers and thrombosis, and two cases showed episodes of thrombosis without intestinal ulcers. All these five cases featured trisomy 8, while the other 38 MDS patients without trisomy 8 had no episode of either intestinal ulcer or thrombosis. Two of the three cases suffering from multiple intestinal ulcers were treated with granulocyte-colony stimulating factor (G-CSF), which resulted in aggravation of the symptoms. Although the influence of G-CSF on such symptoms in MDS patients with trisomy 8 remains unclear, it seems advisable to exercise caution in the use of G-CSF when an MDS patient with trisomy 8 has intestinal ulcers or thrombosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D010437 Peptic Ulcer Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). Gastroduodenal Ulcer,Marginal Ulcer,Gastroduodenal Ulcers,Marginal Ulcers,Peptic Ulcers,Ulcer, Gastroduodenal,Ulcer, Marginal,Ulcer, Peptic,Ulcers, Gastroduodenal,Ulcers, Marginal,Ulcers, Peptic
D002898 Chromosomes, Human, Pair 8 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 8
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075202 Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Contraindications, Physical Agent,Medical Contraindications,Agent Contraindication, Physical,Agent Contraindications, Physical,Contraindication,Contraindication, Medical,Contraindication, Physical Agent,Contraindications, Medical,Medical Contraindication,Physical Agent Contraindication,Physical Agent Contraindications
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
March 2012, World journal of gastroenterology,
S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
April 2023, Zhonghua nei ke za zhi,
S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
January 2006, Internal medicine (Tokyo, Japan),
S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
January 2015, Acta medica Okayama,
S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
March 2021, La Revue de medecine interne,
S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
April 2015, Intestinal research,
S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
January 2005, Clinical and experimental rheumatology,
S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
June 2021, Rheumatology (Oxford, England),
S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
October 2020, Intestinal research,
S Kimura, and J Kuroda, and T Akaogi, and H Hayashi, and Y Kobayashi, and M Kondo
January 2020, Leukemia research reports,
Copied contents to your clipboard!